跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 43,534 条关于
“Meituan Long-Z Investment”
全部
43,534
临床试验
28,525
药物
631
机构
304
资讯
14,074
9个月前
Allink Biotherapeutics Raises $47M to Advance Two ADC Programs in Global Phase I Trials
去年
UnitedHealthcare to Require DEX Z-Codes for Molecular Diagnostic Tests in Phase 3
9个月前
AI-Driven Study Identifies (Z)-Endoxifen as Promising Therapeutic Candidate for Glioblastoma
9天前
FDA Grants Priority Review to Intellia's Lonvo-z, an In Vivo CRISPR Therapy for Hereditary Angioedema
去年
Atossa's (Z)-Endoxifen Shows 77.7% Tumor Reduction in Phase 2 Breast Cancer Trial
去年
Atossa Therapeutics Shifts Focus to Metastatic Breast Cancer with (Z)-Endoxifen, Strengthens Patent Portfolio
8个月前
Ping An Biomedical Secures $90 Million in Strategic Investments to Accelerate Biopharmaceutical Innovation
去年
CRISPR Therapy Nex-Z Shows Promise in ATTR-CM Phase 1 Trial
去年
Atossa Therapeutics Streamlines Phase II Breast Cancer Trial Design While Advancing (Z)-Endoxifen Development
9个月前
Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen in Duchenne Muscular Dystrophy
第 1 页,共 1408 页
上一页
下一页